Effect of cleavage mutants on syncytium formation directed by the wild- type fusion protein of newcastle disease virus

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 3789-3795

  Li, Zengji ^a   Sergel, Theresa ^a,b   Razvi, Enal ^a,c   Morrison, Trudy ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b KING'S COLLEGE   (United States)

^c Frost and Sullivan   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; HUMAN; NEWCASTLE DISEASE PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; SYNCYTIUM; VIRUS MUTATION;

EID: 0031978860     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.3789-3795.1998     Document Type: Article

References (29)

1. Bagai, S., and R. A. Lamb. 1995. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69:6712-6719.
2. Blumenthal, R., K. P. Sarkar, S. Durell, D. E. Howard, and S. J. Morris. 1996. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J. Cell Biol. 135:63-71.
3. Campbell, M. J. 1995. Lipofection reagents prepared by a simple ethanol injection technique. BioTechniques 18:1027-1032.
4. Collins, P., and G. Mottet. 1991. Posttranslational processing and oligomerization of the fusion glycoproteins of human respiratory syncytial virus. J. Gen. Virol. 72:3095-3101.
5. Danieli, T., S. L. Pelletier, Y. I. Henis, and J. M. White. 1996. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 133:559-569.
6. Freed, E. O., E. L. Delwart, J. G. L. Buchschacher, and A. T. Panganiban. 1992. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. USA 89:70-74.
7. Hernandez, L. D., L. R. Hoffman, T. G. Wolfsberg, and J. M. White. 1996. Virus-cell and cell-cell fusion. Annu. Rev. Cell Biol. 12:627-661.
8. Herskowitz, I. 1987. Functional inactivation of genes by dominant negative mutations. Nature 329:219-222.
9. Lamb, R. A. 1993. Paramyxovirus fusion: a hypothesis of changes. Virology 197:1-11.
10. Lamb, R. A., and D. Kolakofsky. 1996. Paramyxoviridae: the viruses and their replication, p. 1177-1206. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
11. McGinnes, L., T. Sergel, and T. G. Morrison. 1993. Mutations in the transmembrane domain of the HN protein of Newcastle disease virus affect the structure and activity of the protein. Virology 196:101-110.
12. McGinnes, L. W., and T. G. Morrison. 1994. The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus. Virology 200:470-483.
13. Monck, J. R., and J. M. Fernandez. 1992. The exocytotic fusion pore. J. Cell Biol. 119:1395-1404.
14. 1 of the Newcastle disease virus fusion protein in cleavage and fusion. Virology 193:997-1000.
15. Morrison, T., L. J. Ward, and A. Semerjian. 1985. Intracellular processing of the Newcastle disease virus fusion glycoprotein. J. Virol. 53:851-857.
16. Nagai, Y., and H. D. Klenk. 1977. Activation of precursors to both glycoproteins of Newcastle disease virus by proteolytic cleavage. Virology 77:125-134.
17. Reitter, J. N., T. Sergel, and T. G. Morrison. 1995. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69:5995-6004.
18. Russell, R., R. G. Paterson, and R. A. Lamb. 1994. Studies with crosslinking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology 199:160-168.
19. Sakaguchi, T., T. Toyoda, B. Gotoh, N. M. Inocencio, K. Kuma, T. Miyata, and Y. Nagai. 1989. Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology 169:260-272.
20. Sakaguchi, T., Q. Tu, L. H. Pinto, and R. A. Lamb. 1997. The active oligomeric state of the minimalistic influenza M2 ion channel is a tetramer. Proc. Natl. Acad. Sci. USA 94:5000-5005.
21. Scheid, A., and P. W. Choppin. 1974. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive protein of Sendai virus. Virology 57:470-490.
22. Scheid, A., and P. W. Choppin. 1978. Two disulfide-linked polypeptide chains constitute active F protein of paramyxoviruses. Virology 80:51-66.
23. Sechoy, O., J. R. Philippot, and A. Bienvenue. 1987. F protein-F protein interaction within the Sendai virus identified by native bonding of chemical cross-linking. J. Biol. Chem. 262:11519-11523.
24. Sergel, T., L. W. McGinnes, and T. G. Morrison. 1993. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity. Virology 196:831-834.
25. Sergel, T., L. W. McGinnes, M. E. Peeples, and T. G. Morrison. 1993. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 193:717-726.
26. Sergel, T., and T. Morrison. 1995. Mutations in the cytoplasmic domain of the fusion glycoprotein of Newcastle disease virus depress syncytia formation. Virology 210:264-272.
27. Sergel-Germano, T., C. McQuain, and T. Morrison. 1994. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68:7654-7658.
28. Wang, C., G. Raghu, T. Morrison, and M. E. Peeples. 1992. Intracellular processing of the paramyxovirus F protein: critical role of the predicted amphipathic alpha helix adjacent to the fusion domain. J. Virol. 66:4161-4169.
29. White, J. M. 1992. Membrane fusion. Science 258:917-924.